Awakn Life Sciences (TSE:AWKN) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Awakn Life Sciences has announced a binding letter of intent for its acquisition by Graft Polymer, a UK-based biotechnology company, marking a significant milestone for both companies. Each Awakn shareholder will receive 46.67 Graft shares for each common share, representing a 110.54% premium. This acquisition aims to enhance shareholder value and expand their reach in addressing mental health and addiction disorders.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
